Tarik Kanouni

982 total citations
22 papers, 306 citations indexed

About

Tarik Kanouni is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Tarik Kanouni has authored 22 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in Tarik Kanouni's work include Complement system in diseases (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Tarik Kanouni is often cited by papers focused on Complement system in diseases (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Tarik Kanouni collaborates with scholars based in France, Mali and United States. Tarik Kanouni's co-authors include Bernard Klein, Jean‐François Rossi, Philippe Quittet, Guillaume Cartron, Zhaoyang Lu, Marion Baudard, Nathalie Fegueux, Marion Larroque, Patrice Céballos and Martín Villalba and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tarik Kanouni

20 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarik Kanouni France 9 157 116 99 98 66 22 306
Massimo Pini Italy 10 136 0.9× 115 1.0× 112 1.1× 128 1.3× 119 1.8× 26 382
Elena Sebastián Spain 9 82 0.5× 92 0.8× 87 0.9× 70 0.7× 63 1.0× 34 260
Minodora Mazur Moldova 6 140 0.9× 113 1.0× 92 0.9× 52 0.5× 91 1.4× 20 368
Hélène Demarquette France 8 199 1.3× 106 0.9× 168 1.7× 158 1.6× 116 1.8× 20 371
Sandra P. Susanibar-Adaniya United States 7 172 1.1× 52 0.4× 55 0.6× 137 1.4× 57 0.9× 28 332
Zhihua Tian China 5 107 0.7× 280 2.4× 169 1.7× 54 0.6× 44 0.7× 8 404
Abigail S. Kelliher United States 7 90 0.6× 95 0.8× 135 1.4× 161 1.6× 178 2.7× 9 369
Alessandro Previtali United States 7 257 1.6× 76 0.7× 101 1.0× 111 1.1× 43 0.7× 18 374
Olivia Minelli Italy 10 121 0.8× 99 0.9× 70 0.7× 197 2.0× 102 1.5× 12 325
José María Fernández‐Rañada Spain 10 127 0.8× 122 1.1× 136 1.4× 93 0.9× 134 2.0× 16 349

Countries citing papers authored by Tarik Kanouni

Since Specialization
Citations

This map shows the geographic impact of Tarik Kanouni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarik Kanouni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarik Kanouni more than expected).

Fields of papers citing papers by Tarik Kanouni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarik Kanouni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarik Kanouni. The network helps show where Tarik Kanouni may publish in the future.

Co-authorship network of co-authors of Tarik Kanouni

This figure shows the co-authorship network connecting the top 25 collaborators of Tarik Kanouni. A scholar is included among the top collaborators of Tarik Kanouni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarik Kanouni. Tarik Kanouni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Barbet, Christelle, François Provôt, Pascale Poullin, et al.. (2024). Obinutuzumab in Rituximab Refractory or Intolerant Immune-Mediated Thrombotic Thrombocytopenic Purpura. Blood. 144(Supplement 1). 139–139.
3.
Kanouni, Tarik, et al.. (2023). Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis. Journal of Translational Autoimmunity. 6. 100194–100194. 2 indexed citations
4.
Wyngaert, Zoé Van de, Florent Malard, Cyrille Hulin, et al.. (2023). Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03). SHILAP Revista de lepidopterología. 5(1). 38–42. 1 indexed citations
5.
Martis, Nihal, Matthieu Jamme, Claire Pouteil‐Noble, et al.. (2021). Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA. European Journal of Internal Medicine. 93. 78–86. 12 indexed citations
6.
Boissier, Elodie, Julien Baleine, M. Rodière, et al.. (2021). Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review. Blood Advances. 6(2). 495–502. 10 indexed citations
7.
8.
Lamure, Sylvain, Anne-Laure Gagez, Jérémy Delage, et al.. (2020). A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment. Journal of Clinical Medicine. 9(7). 2204–2204. 8 indexed citations
9.
Kangro, Kadri, Matthieu Jamme, Sandrine Malot, et al.. (2020). Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura. HemaSphere. 4(4). e462–e462. 4 indexed citations
10.
Thiéblemont, Catherine, Steven Le Gouill, Roberta Di Blasi, et al.. (2019). REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM. Hematological Oncology. 37(S2). 301–301. 7 indexed citations
11.
Couture, Patrice, Anne‐Sophie Moreau, Marc Pineton de Chambrun, et al.. (2018). FRI0302 Systemic lupus erythematosus-associated thrombotic microangiopathies in 60 patients: clinical features, prognosis and treatment in a french multicentric cohort. Annals of the Rheumatic Diseases. 77. 688–689. 3 indexed citations
12.
Trusson, Rémi, Jean‐Emmanuel Serre, Ilan Szwarc, et al.. (2016). Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients. Transplantation Proceedings. 48(6). 1927–1933. 4 indexed citations
13.
Orsini, Mattéa, Patrice Céballos, Nathalie Fegueux, et al.. (2014). ControlledEpstein–Barr virus reactivation after allogeneic transplantation is associated with improved survival. European Journal Of Haematology. 92(5). 421–428. 28 indexed citations
14.
Gouill, Steven Le, Nicolaus Kröger, Nathalie Dhédin, et al.. (2012). Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience. Annals of Oncology. 23(10). 2695–2703. 47 indexed citations
15.
Bret, Caroline, Dirk Hose, Thierry Rème, et al.. (2011). Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment. Experimental Hematology. 39(5). 546–557.e8. 16 indexed citations
16.
Caraux, Anouk, Martín Pérez‐Andrés, Marion Larroque, et al.. (2010). Mobilization of plasma cells in healthy individuals treated with granulocyte colony-stimulating factor for haematopoietic stem cell collection. Immunology. 132(2). 266–272. 9 indexed citations
17.
Condomines, Maud, Jean‐Luc Veyrune, Marion Larroque, et al.. (2009). Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy. The Journal of Immunology. 184(2). 1079–1084. 33 indexed citations
18.
Cartron, Guillaume, Zhaoyang Lu, Marion Baudard, et al.. (2008). Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Rituximab in Patients With Relapsed Follicular Lymphoma: Results of a Phase II Study. Journal of Clinical Oncology. 26(16). 2725–2731. 70 indexed citations
19.
Fegueux, Nathalie, Lu Zhang, Éric Legouffe, et al.. (2005). Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects. Bone Marrow Transplantation. 36(9). 771–779. 44 indexed citations
20.
Cristol, Jean‐Paul, et al.. (1997). Cholesterol biosynthesis in normocholesterolemic patients after cholesterol removal by plasmapheresis. Journal of Clinical Apheresis. 12(3). 110–115. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026